{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-022679","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.005717+00:00","generated_at":"2026-05-22T13:47:18.476311+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q1 2025 revenue $1.53B, net income $12M; reaffirms FY 2025 guidance","bullets":["Total revenue $1.53B (down 4% YoY); Medicare Advantage members 491,000 (down 6%).","Net income $12M vs loss $6M; Adjusted EBITDA $21M vs $29M.","Medical margin $128M includes $22M negative impact from prior year claims.","FY 2025 guidance: revenue $5.85-$6.025B; medical margin $275-$325M; Adj EBITDA ($95)-($55)M.","2025 gross medical cost trend estimated at 6.3% (vs 7.1% in 2024); net trend 5.3%."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-022679","json":"https://secwatch.observer/filing/0001628280-25-022679.json","markdown":"https://secwatch.observer/filing/0001628280-25-022679.md","text":"https://secwatch.observer/filing/0001628280-25-022679.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025022679/0001628280-25-022679-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025022679/agl-20250506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T13:47:18.476311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}